Examiner: MAHADEVAN, JANAKI ANANTH

Tech Center 3700 • Art Units: 1633 1637 1656 1693 3781

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-70.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

1.2%

§101 Eligibility

9.8%

§102 Novelty

42.7%

§103 Obviousness

23.2%

§112 Clarity

App #	Title	Status	Assignee
18552676	NOVEL FORMS OF CYCLIC DINUCLEOTIDE COMPOUNDS	Non-Final OA	Merck Sharp & Dohme LLC
18294592	METHOD OF TREATING VETERINARY VIRAL DISEASES	Non-Final OA	Intervet Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.